Purpose The purpose of this study was to analyze the effects of estrogen deficiency and
hormone replacement therapy (HRT) on fibrinolytic activity in a rat mode of surgically …

Aim: The purpose of this study was to determine the changes of biochemical risk factors for
thromboembolisms using different administration routes of early estrogen replacement …

Hormone replacement therapy has been associated with a reduction in cardiovascular
disease. One possible mechanism may be the effects of hormone replacement on the …

Introduction The objective of this study was to estimate the effects of different doses of oral
hormone therapy (HT) on thrombin generation and fibrinolytic activity in postmenopausal …

Background/Aim: Hormone replacement therapy during menopause increases the risk of
thromboembolic diseases and cancer, so safety alternative therapeutic strategies are …

Objective To examine the effects of continuous combined estrogen-progesterone
replacement therapy on coagulation and natural anticoagulant systems in spontaneous …

INTRODUCTION: During extrinsic coagulation pathway, a complex is developed between
factor VII, calcium and tissue factor (a cell membrane lipoprotein that is exposed after cell …

Objective To determine the effect of oestrogen dose and progestogen type on the
coagulation and fibrinolytic systems of a group of normal healthy women taking three …

Objective Blood coagulation and fibrinolytic variables were evaluated in 46 Brazilian women
treated with either of two monophasic oral contraceptives (OC), containing 30 or 20 microg …

Background: Hormonal contraceptive pills are the most used reversible method for familiar
planning in Brazil. The combined pill, with synthetic analogs of estrogen and progestin, is …